Search for authorsSearch for similar articles
19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Length of hospital stay for elective electrophysiological procedures: a survey from the European Heart Rhythm Association

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          Electrophysiological (EP) operations that have traditionally involved long hospital lengths of stay (LOS) are now being undertaken as day case procedures. The coronavirus disease-19 pandemic served as an impetus for many centres to shorten LOS for EP procedures. This survey explores LOS for elective EP procedures in the modern era.

          Methods and results

          An online survey consisting of 27 multiple-choice questions was completed by 245 respondents from 35 countries. With respect to de novo cardiac implantable electronic device (CIED) implantations, day case procedures were reported for 79.5% of implantable loop recorders, 13.3% of pacemakers (PMs), 10.4% of implantable cardioverter defibrillators (ICDs), and 10.2% of cardiac resynchronization therapy (CRT) devices. With respect to CIED generator replacements, day case procedures were reported for 61.7% of PMs, 49.2% of ICDs, and 48.2% of CRT devices. With regard to ablations, day case procedures were reported for 5.7% of atrial fibrillation (AF) ablations, 10.7% of left-sided ablations, and 17.5% of right-sided ablations. A LOS ≥ 2 days for CIED implantation was reported for 47.7% of PM, 54.5% of ICDs, and 56.9% of CRT devices and for 54.5% of AF ablations, 42.2% of right-sided ablations, and 46.1% of left-sided ablations. Reimbursement (43–56%) and bed availability (20–47%) were reported to have no consistent impact on the organization of elective procedures.

          Conclusion

          There is a wide variation in the LOS for elective EP procedures. The LOS for some procedures appears disproportionate to their complexity. Neither reimbursement nor bed availability consistently influenced LOS.

          Graphical Abstract

          Graphical abstract

          Related collections

          Most cited references78

          • Record: found
          • Abstract: not found
          • Article: not found

          2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Evaluating the quality of medical care.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              European Society of Cardiology: cardiovascular disease statistics 2021

              Aims This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) statistics for the 57 ESC member countries. Methods and results Statistics pertaining to 2019, or the latest available year, are presented. Data sources include the World Health Organization, the Institute for Health Metrics and Evaluation, the World Bank, and novel ESC sponsored data on human and capital infrastructure and cardiovascular healthcare delivery. New material in this report includes sociodemographic and environmental determinants of CVD, rheumatic heart disease, out-of-hospital cardiac arrest, left-sided valvular heart disease, the advocacy potential of these CVD statistics, and progress towards World Health Organization (WHO) 2025 targets for non-communicable diseases. Salient observations in this report: (i) Females born in ESC member countries in 2018 are expected to live 80.8 years and males 74.8 years. Life expectancy is longer in high income (81.6 years) compared with middle-income (74.2 years) countries. (ii) In 2018, high-income countries spent, on average, four times more on healthcare than middle-income countries. (iii) The median PM2.5 concentrations in 2019 were over twice as high in middle-income ESC member countries compared with high-income countries and exceeded the EU air quality standard in 14 countries, all middle-income. (iv) In 2016, more than one in five adults across the ESC member countries were obese with similar prevalence in high and low-income countries. The prevalence of obesity has more than doubled over the past 35 years. (v) The burden of CVD falls hardest on middle-income ESC member countries where estimated incidence rates are ∼30% higher compared with high-income countries. This is reflected in disability-adjusted life years due to CVD which are nearly four times as high in middle-income compared with high-income countries. (vi) The incidence of calcific aortic valve disease has increased seven-fold during the last 30 years, with age-standardized rates four times as high in high-income compared with middle-income countries. (vii) Although the total number of CVD deaths across all countries far exceeds the number of cancer deaths for both sexes, there are 15 ESC member countries in which cancer accounts for more deaths than CVD in males and five-member countries in which cancer accounts for more deaths than CVD in females. (viii) The under-resourced status of middle-income countries is associated with a severe procedural deficit compared with high-income countries in terms of coronary intervention, ablation procedures, device implantation, and cardiac surgical procedures. Conclusion Risk factors and unhealthy behaviours are potentially reversible, and this provides a huge opportunity to address the health inequalities across ESC member countries that are highlighted in this report. It seems clear, however, that efforts to seize this opportunity are falling short and present evidence suggests that most of the WHO NCD targets for 2025 are unlikely to be met across ESC member countries.
                Bookmark

                Author and article information

                Contributors
                Journal
                Europace
                Europace
                europace
                Europace
                Oxford University Press (US )
                1099-5129
                1532-2092
                October 2023
                04 October 2023
                04 October 2023
                : 25
                : 10
                : euad297
                Affiliations
                Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena , Via del Pozzo, 71, Modena 41124, Italy
                mHealth and Health Economics and PROM Committee of EHRA (European Heart Rhythm Association)
                Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena , Via del Pozzo, 71, Modena 41124, Italy
                Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia , Modena, Italy
                mHealth and Health Economics and PROM Committee of EHRA (European Heart Rhythm Association)
                Department of Cardiology, Aston Medical Research Institute, Aston Medical School, Aston University , Aston Triangle, Birmingham B4 7ET, UK
                mHealth and Health Economics and PROM Committee of EHRA (European Heart Rhythm Association)
                Department of Cardiology, H.U.B.-Hôpital Erasme, Université Libre de Bruxelles , Brussels 1070, Belgium
                Medizinische Klinik III, CCB am Agaplesion Markus Krankenhaus , Frankfurt am Main, Germany
                mHealth and Health Economics and PROM Committee of EHRA (European Heart Rhythm Association)
                Department of Medicine; Solna, Karolinska Institutet and ME Cardiology, Karolinska University Hospital , Norrbacka S1:02, Eugeniavagen 27, Stockholm 171 77, Sweden
                mHealth and Health Economics and PROM Committee of EHRA (European Heart Rhythm Association)
                Department of Cardiology, Medical University Hospital , Heidelberg, Germany
                Hannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School , Hannover 30625, Germany
                Department of Cardiology, Ministry of Interior and Administration National Medical Institute , Warsaw, Poland
                Ordensklinikum Linz Elisabethinen , Interne II/Kardiologie und Interne Intensivmedizin, Fadingerstraße 1, 4020 Linz, Austria
                Arrhythmia-Robotic Electrophysiology Unit, La Paz University Hospital, IdiPAZ, Universidad Autonoma , Madrid, Spain
                Author notes
                Corresponding author. Tel: +39 0594225836. E-mail address: giuseppe.boriani@ 123456unimore.it

                Conflict of interest: G.B. reported small speaker fees from Bayer, Boehringer Ingelheim, Boston, Daiichi Sankyo, Microport, Janssen, and Sanofi outside of the submitted work. R.C.-A. reported small educational speakers fees from Abbott and Boston Scientific. J.C. reports lecture fees/honoraria, educational grants Boston Scientific, Medtronic, and Biosense Webster outside of the submitted work. M.M.Z. reports lecture fees/honoraria, educational grants, and travel support by Medtronic, Boston Scientific, Bayer Vital, ZOLL CMS, and Pfizer. D.D. received modest lecture honorary fees from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CVRx, Medtronic, Microport, Pfizer, and Zoll. M.M.F. reports speaker/consultation fees from Medtronic, Abbott, and ZOLL. The other authors did not report conflicts of interest to disclose outside of the submitted work.

                Author information
                https://orcid.org/0000-0002-9820-4815
                https://orcid.org/0000-0003-3403-3364
                https://orcid.org/0000-0002-2176-0223
                https://orcid.org/0000-0002-3876-6074
                https://orcid.org/0000-0002-2355-6015
                https://orcid.org/0000-0002-4966-1315
                https://orcid.org/0000-0001-9373-8132
                https://orcid.org/0000-0003-2996-6338
                https://orcid.org/0000-0003-1673-7712
                https://orcid.org/0000-0002-8965-8495
                https://orcid.org/0000-0002-1737-1903
                Article
                euad297
                10.1093/europace/euad297
                10563655
                37789664
                19f71234-d245-4e76-a00d-8ac10712c820
                © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 02 August 2023
                : 24 September 2023
                Page count
                Pages: 8
                Categories
                EHRA Survey
                AcademicSubjects/MED00200
                Eurheartj/1
                Eurheartj/2

                Cardiovascular Medicine
                ablation,arrhythmia,implantable defibrillator,electrophysiology,pacemaker,ehra survey

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content55

                Cited by5

                Most referenced authors1,938